EUVIMEDEUVIMED entdecken
Crossref

Copper-Driven Phyto-Nanotechnology in Gastroretentive Drug Delivery: A Precision Strategy for H. Pylori Eradication

Kavya Kavya, Vedamurthy Joshi

International Journal of Drug Delivery Technology · 29.06.2026 · 16 (59s)

DOI: 10.25258/ijddt.16.59s.69 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 29.06.2026. Verfasst von Kavya Kavya und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The infection Helicobacter pylori is one of the most common causes of chronic gastritis, peptic ulcer disease, mucosaassociated lymphoid tissue lymphoma, and gastric adenocarcinoma. Thus, this remains a priority global health burden. Conventional antibiotic-based eradication regimens have surely improved clinical outcomes, but their effectiveness is increasingly compromised because of rising antibiotic resistance, poor drug stability in the acidic gastric milieu, limited mucus penetration, and inadequate local drug residence time. Next-generation gastroretentive drug delivery systems (GRDDS), such as stimuli-responsive hydrogels and mucoin-binding ligands, have been found to be better drug delivery platforms compared to the earlier floating tablets. The earlier floating tablets were based on the buoyancy concept only, whereas the advanced drug delivery platforms are able to deliver the drug directly to the H. pylori niche by bypassing the gastric emptying cycle, which is only 30-120 minutes. The following review explores the therapeutic potentials of copper nanoparticles and bioactive phytochemicals incorporated within gastroretentive drug delivery systems as a novel and synergistic strategy for the eradication of Helicobacter pylori. CuNPs have a distinct multifunctional antibacterial activity that distinguishes them from other metallic nanoparticles, including silver and bismuth. In addition to non-specific oxidative stress, CuNPs have been found to have specific immunomodulation via ALPK1 and urease inhibition. This offers a cost-effective and chemically diverse alternative to precious metal nanoparticles. Phytochemicals, including curcumin, catechins, allicin, quercetin, and resveratrol, contribute anti-H. pylori, anti-inflammatory, and mucosal protective effects with reduced potential for resistance development. The integration of these agents into mucoadhesive, floating, or pH-responsive GRDDS enables site-specific delivery, improved stability, sustained release, and extended interaction time with gastric mucosa. This review discusses new mechanistic paradigms, formulation strategies, synergistic interactions, and translational challenges and underlines the importance of rational design and standardized safety testing for nanoparticles. CuNP- and phytochemical-based GRDDS collectively hold promise for a new generation of therapy for the treatment of H. pylori infections beyond that which is possible with the current armamentarium.

Zitieren

APA

Kavya, K., & Joshi, V. (2026). Copper-Driven Phyto-Nanotechnology in Gastroretentive Drug Delivery: A Precision Strategy for H. Pylori Eradication. International Journal of Drug Delivery Technology, 16(59s). https://doi.org/10.25258/ijddt.16.59s.69

Vancouver

Kavya K, Joshi V. Copper-Driven Phyto-Nanotechnology in Gastroretentive Drug Delivery: A Precision Strategy for H. Pylori Eradication. International Journal of Drug Delivery Technology. 2026;16(59s). doi:10.25258/ijddt.16.59s.69

BibTeX
@article{Kavya2026,
  author = {Kavya, Kavya and Joshi, Vedamurthy},
  title = {Copper-Driven Phyto-Nanotechnology in Gastroretentive Drug Delivery: A Precision Strategy for H. Pylori Eradication},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {59s},
  doi = {10.25258/ijddt.16.59s.69}
}
Kostenlos starten →